0001831900-20-000001.txt : 20201112 0001831900-20-000001.hdr.sgml : 20201112 20201112121033 ACCESSION NUMBER: 0001831900-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 EFFECTIVENESS DATE: 20201112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Equilibre BioPharmaceuticals Corp. CENTRAL INDEX KEY: 0001831900 IRS NUMBER: 853484646 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380339 FILM NUMBER: 201305013 BUSINESS ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-308-6000 MAIL ADDRESS: STREET 1: 300 EAST 33RD STREET STREET 2: APT 14 M CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001831900 Equilibre BioPharmaceuticals Corp. 300 EAST 33RD STREET APT 14 M NEW YORK NY NEW YORK 10016 212-308-6000 DELAWARE None None Corporation true 2020 Steven Gordon 300 East 33rd Street Apt 14 M New York NY NEW YORK 10016 Executive Officer Sam Waksal 300 East 33rd Street Apt 14 M New York NY NEW YORK 10016 Executive Officer Francois Maisonrouge 300 East 33rd Street Apt 14 M New York NY NEW YORK 10016 Director Joel Marcus 300 East 33rd Street Apt 14 M New York NY NEW YORK 10016 Director David Friedman 300 East 33rd Street Apt 14 M New York NY NEW YORK 10016 Director Pharmaceuticals Decline to Disclose 06b false 2020-11-04 false true false 0 35799973 25799973 10000000 false 14 0 0 0 false Equilibre BioPharmaceuticals Corp. Steven Gordon Steven Gordon Secretary 2020-11-12